Bird & Be offers direct-to-consumer, personalized at-home kits designed to optimize fertility outcomes for people with sperm and eggs. The company optimizes care through two pillars: Education (content and patented early screening diagnostics) and Action (custom supplements, prescriptions and a referral network). Bird & Be introduced its signature line of supplements in July. It plans to launch at-home tools this fall, including a patent-pending urine stick Ovarian Reserve test, pregnancy, ovulation and sperm tests. The company aims to break down barriers to access via information, affordable products, and digitizing basic protocols to accelerate time to care. Bird & Be announced a $1.8M financing round led by BAM Ventures.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Sep 2021